Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Single-Arm Study of HTIC (Heterologous Type I Collagen) Intradermal Injections for the Medical Treatment of Dermal Defects Due to Scarring, Hypotonia, and Hypotrophy
Authors not listed
Centro Studi Dermatologici S.r.l. · 2025
Abstract
This clinical trial aims to evaluate the efficacy of the experimental medical device HTIC, which contains Type I collagen of animal origin, in treating skin defects such as scars, loss of tone, and volume in certain areas of the face and body. HTIC is administered through an injection technique applied under the skin. The main research question is: "Is it possible to achieve clinical improvement of skin defects through the use of the experimental device HTIC?"
Additionally, the study has the following secondary objectives:
* To assess any discomfort experienced during administration;
* To evaluate the subject's level of satisfaction following the entire treatment;
* To assess the safety and tolerability of the experimental device HTIC. HTIC is a sterile powder composed solely of animal-derived collagen (heterologous bovine Type I collagen, allergen-free and compliant with current regulations), packaged in 10 ml glass vials. Each vial contains 100 mg of sterile bovine Type I collagen powder.
The trial will be conducted at a single site in Italy, specifically at the Federico II University Hospital. A total of 45 subjects will participate in the study.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Anonymous. (2025). A Single-Arm Study of HTIC (Heterologous Type I Collagen) Intradermal Injections for the Medical Treatment of Dermal Defects Due to Scarring, Hypotonia, and Hypotrophy. <em>Centro Studi Dermatologici S.r.l.</em>. https://clinicaltrials.gov/study/NCT07153393
Vancouver
Anonymous. A Single-Arm Study of HTIC (Heterologous Type I Collagen) Intradermal Injections for the Medical Treatment of Dermal Defects Due to Scarring, Hypotonia, and Hypotrophy. Centro Studi Dermatologici S.r.l.. 2025.
BibTeX
@misc{anon2025ASingl,
title = {A Single-Arm Study of HTIC (Heterologous Type I Collagen) Intradermal Injections for the Medical Treatment of Dermal Defects Due to Scarring, Hypotonia, and Hypotrophy},
author = {Anonymous},
journal = {Centro Studi Dermatologici S.r.l.},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
TAO An 2023
Open access · US-GOV
Effects of A Home-based Psychoeducation Programme on Subjective Well-being for Older Adults With Frailty in the Community: A Feasibility Trial
Gulf Bird 2026
Open access · US-GOV
A Clinical Trial to Evaluate the Effects of Naila's Collagen Marine Plus Food Supplement on Skin Hydration, Elasticity, Fine Lines and Wrinkles, and Hair and Nail Health
University of Arizona 2022
Open access · US-GOV
Evaluating the Neurocomputational Mechanisms of Explore-Exploit Decision Making in Older Adults
Chinese University of Hong Kong 2026
Open access · US-GOV
Telehealth-Supported Discharge Programme on Health Outcomes Among Frail Older Adults: A Pilot Randomized Controlled Trial
The Hong Kong Polytechnic University 2024
Open access · US-GOV
Effectiveness of a Dyadic e-Health System on Enhancing Healthy Lifestyles of Older Adults With Sarcopenia: A Randomized Controlled Trial
Phitogen Beauty Labs SRL 2022
Open access · US-GOV